AMUNDI ASSET MANAGEMENT US, INC. - REATA PHARMACEUTICALS INC ownership

REATA PHARMACEUTICALS INC's ticker is RETA and the CUSIP is 75615P103. A total of 202 filers reported holding REATA PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is 1.43 and the average weighting 0.5%.

Quarter-by-quarter ownership
AMUNDI ASSET MANAGEMENT US, INC. ownership history of REATA PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2020$14,557,000
+19.7%
117,758
-5.7%
0.01%
-7.7%
Q3 2020$12,161,000
-39.3%
124,834
-2.8%
0.01%
-45.8%
Q2 2020$20,036,000
+0.0%
128,418
-7.5%
0.02%
-31.4%
Q1 2020$20,034,000
-31.2%
138,797
-2.5%
0.04%
+2.9%
Q4 2019$29,109,000
+94.7%
142,390
-23.5%
0.03%
+54.5%
Q3 2019$14,949,000
-13.9%
186,191
+1.2%
0.02%
+57.1%
Q2 2019$17,353,000
+51.4%
183,919
+37.1%
0.01%
-12.5%
Q1 2019$11,462,000134,1050.02%
Other shareholders
REATA PHARMACEUTICALS INC shareholders Q1 2021
NameSharesValueWeighting ↓
DekaBank Deutsche Girozentrale 17,000$2,9300.01%
PUBLIC EMPLOYEES RETIREMENT ASSOCIATION OF COLORADO 93,711$1,6120.00%
IFP Advisors, Inc 300$51,7080.00%
View complete list of REATA PHARMACEUTICALS INC shareholders